1. Home
  2. KNTK vs BEAM Comparison

KNTK vs BEAM Comparison

Compare KNTK & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinetik Holdings Inc.

KNTK

Kinetik Holdings Inc.

HOLD

Current Price

$47.98

Market Cap

3.5B

Sector

Utilities

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$32.75

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNTK
BEAM
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
KNTK
BEAM
Price
$47.98
$32.75
Analyst Decision
Buy
Buy
Analyst Count
12
12
Target Price
$48.58
$50.75
AVG Volume (30 Days)
1.1M
2.6M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
6.53%
N/A
EPS Growth
157.84
82.31
EPS
N/A
N/A
Revenue
$160,617,000.00
$24,000.00
Revenue This Year
$7.80
N/A
Revenue Next Year
$13.93
$33.77
P/E Ratio
N/A
N/A
Revenue Growth
8.23
33.33
52 Week Low
$31.33
$15.60
52 Week High
$51.51
$38.26

Technical Indicators

Market Signals
Indicator
KNTK
BEAM
Relative Strength Index (RSI) 51.05 48.29
Support Level $44.64 $23.83
Resistance Level $49.06 $35.18
Average True Range (ATR) 1.41 2.84
MACD 0.08 -0.06
Stochastic Oscillator 42.97 21.32

Price Performance

Historical Comparison
KNTK
BEAM

About KNTK Kinetik Holdings Inc.

Kinetik Holdings Inc is a midstream operator that provides comprehensive gathering, transportation, compression, processing and treating services. Its activities also include NGL stabilization and transportation, produced water gathering and disposal, and crude oil gathering, stabilization, storage, and transportation. The company operates in two reportable segments: i) The Midstream Logistics segment operates under three service offerings: 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. ii) The Pipeline Transportation segment consists of two EMI Pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: